Ontology highlight
ABSTRACT:
SUBMITTER: Amendola LM
PROVIDER: S-EPMC4908185 | biostudies-literature | 2016 Jun
REPOSITORIES: biostudies-literature
Amendola Laura M LM Jarvik Gail P GP Leo Michael C MC McLaughlin Heather M HM Akkari Yassmine Y Amaral Michelle D MD Berg Jonathan S JS Biswas Sawona S Bowling Kevin M KM Conlin Laura K LK Cooper Greg M GM Dorschner Michael O MO Dulik Matthew C MC Ghazani Arezou A AA Ghosh Rajarshi R Green Robert C RC Hart Ragan R Horton Carrie C Johnston Jennifer J JJ Lebo Matthew S MS Milosavljevic Aleksandar A Ou Jeffrey J Pak Christine M CM Patel Ronak Y RY Punj Sumit S Richards Carolyn Sue CS Salama Joseph J Strande Natasha T NT Yang Yaping Y Plon Sharon E SE Biesecker Leslie G LG Rehm Heidi L HL
American journal of human genetics 20160512 6
Evaluating the pathogenicity of a variant is challenging given the plethora of types of genetic evidence that laboratories consider. Deciding how to weigh each type of evidence is difficult, and standards have been needed. In 2015, the American College of Medical Genetics and Genomics (ACMG) and the Association for Molecular Pathology (AMP) published guidelines for the assessment of variants in genes associated with Mendelian diseases. Nine molecular diagnostic laboratories involved in the Clini ...[more]